Clinical trial
Pilot Clinical Trial on the Efficacy and Safety of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy
NCT04766957 is registered in ClinicalTrials.gov with Procare Health Iberia S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Clinical Trial on the Efficacy and Safety of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy
- Lead sponsor
- Procare Health Iberia S.L.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 26, 2020
- Completion date
- December 2, 2022
- Enrollment
- 134 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
vulvovaginal atrophy